Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: Injection
Still deciding? Get samples of $ !
Request Sample

360° Virtual Tour

Diamond Member Since 2025

Suppliers with verified business licenses

Audited Supplier Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Exhibition Experience
The supplier had participated in offline trade shows, you can check the Audit Report for more information
Experienced Team
The supplier has 18 foreign trading staff(s) and 6 staff(s) with over 6 years of overseas trading experience
to see all verified strength labels (26)
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
  • Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection
Find Similar Products
  • Overview
  • Company Profile
Overview

Basic Info.

Model NO.
AMC13009-02
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Powder+Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Standard Available
Bp, Cp
Function
Antibiotics
Delivery Time
30~60 Days
OEM/ODM
Support
Transport Package
Box
Specification
1G/10ML+10ML, 1′S+1′S/BOX
Trademark
Shinepharm, OEM
Origin
China
HS Code
3004201700
Production Capacity
2000000 Vials Per Month

Product Description


Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection

 

Ceftriaxone Sodium for Injection

Indications:
Ceftriaxone is often used (in combination, but not direct, with macrolide and/or aminoglycoside antibiotics) for the treatment of community-acquired or mild to moderate health care-associated pneumonia. It is also a choice drug for treatment of bacterial meningitis. In pediatrics, it is commonly used in febrile infants between 4 and 8 weeks of age who are admitted to the hospital to exclude sepsis.
Contra-indications:
Ceftriaxone is contraindicated in neonates if they require (or are expected to require) treatment with calcium-containing IV solutions, including continuous calcium-containing infusions such as parenteral nutrition because of the risk of precipitation of ceftriaxone-calcium. 
Adverse Effects:
Hypoprothrombinaemia and bleeding are specific side effects. Haemolysis is reported. Biliary sludging is another known though rare adverse effect which occurs primarily in neonates.
Drug Interactions:
Ceftriaxone can interact with a number of medicines. Drugs that can interact with ceftriaxone include, but are not limited to, the following: Warfarin, , Sulfinpyrazone, Calcium.
Storage instructions:
Store below 25ºC. Protect from moisture. Keep out of reach of children.

Certificate of Analysis

Testing terms Standards Results
Shape It is white or off-white crystalline powder; odorless white crystalline powder; odorless
pH 6.0~8.0 6.6
Water 8.0%~11.0% 8.4%
Relative substance Single heterogeneity ≤ 1.0%
Total miscellaneous response ≤4.0%
0.1%
0.3%
Loading difference Comply with the standard Conformity
Visible foreign matter Comply with the standard Conformity
Assay 90.0%-110.0% 99.7%
Company Profile

 

Western Medicines, GMP, Bp Ceftriaxone Sodium for InjectionWestern Medicines, GMP, Bp Ceftriaxone Sodium for Injection

Western Medicines, GMP, Bp Ceftriaxone Sodium for Injection

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier